Pacira BioSciences
PCRX
PCRX
239 hedge funds and large institutions have $1.24B invested in Pacira BioSciences in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 67 increasing their positions, 95 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $1.21B → $1.24B (+$28.4M)
2.41% less ownership
Funds ownership: 109.17% → 106.76% (-2.4%)
29% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 95
Holders
239
Holding in Top 10
2
Calls
$3.13M
Puts
$661K
Top Buyers
| 1 | +$22M | |
| 2 | +$10.1M | |
| 3 | +$4.81M | |
| 4 |
Morgan Stanley
New York
|
+$4.73M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.16M |
Top Sellers
| 1 | -$21.8M | |
| 2 | -$11.3M | |
| 3 | -$10.9M | |
| 4 |
Millennium Management
New York
|
-$10.9M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$8.16M |